Herpesvirus infections of the central nervous system in immunocompromised patients

Therapeutic Advances in Neurological Disorders

Volumn 5, Issue 5, 2012, Pages 279-296

  Meyding Lamade, Uta ^a   Strank, Cornelia ^a  

^a KRANKENHAUS NORDWEST   (Germany)

Author keywords

central nervous system; cytomegalovirus; Epstein Barr virus; herpes simplex virus; herpes viruses; human herpesvirus 6; immunocompromised; varicella zoster virus

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CIDOFOVIR; CORTICOSTEROID; CYTOMEGALOVIRUS VACCINE; DEXAMETHASONE; DOXORUBICIN; FOSCARNET; GANCICLOVIR; GLYCOPROTEIN B; IDOXURIDINE; LETERMOVIR; MIFAMURTIDE; PACLITAXEL; VALACICLOVIR; VALGANCICLOVIR;

AMNESIA; ANALGESIA; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ATAXIA; BURKITT LYMPHOMA; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CHICKENPOX; COGNITIVE DEFECT; CONFUSION; CONGENITAL INFECTION; CONSCIOUSNESS; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; DRUG MEGADOSE; EARLY DIAGNOSIS; EPILEPTIC DISCHARGE; EPSTEIN BARR VIRUS; ETHMOID BONE; FEVER; FOLLOW UP; GENITAL ULCER; GRAFT RECIPIENT; HEADACHE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HERPES ZOSTER; HERPES ZOSTER ENCEPHALITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; LONG TERM CARE; LUMBAR PUNCTURE; LYMPHOMA; MALAISE; MENINGISM; MENINGITIS; MIDDLE CRANIAL FOSSA; MONONUCLEOSIS; NASOPHARYNX CARCINOMA; OLFACTORY EPITHELIUM; PERSONALITY DISORDER; PLEOCYTOSIS; PRIMARY INFECTION; PRIORITY JOURNAL; PROGNOSIS; RASH; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEIZURE; SEROPREVALENCE; SEXUAL TRANSMISSION; SUPERINFECTION; TEMPORAL LOBE; UPPER RESPIRATORY TRACT INFECTION; VARICELLA ZOSTER VIRUS; VESICULAR RASH;

EID: 84870443796     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285612456234     Document Type: Review

References (137)

1. Akhyani N. Fotheringham J. Yao K. Rashti F. Jacobson S. (2006) Efficacy of antiviral compounds in human herpesvirus-6–infected glial cells. J Neurovirol 12: 284–293.
2. Antman K. Chang Y. (2000). Kaposi's sarcoma. N Engl J Med 342: 1027–1038.
3. Arvin A. Whitley R. Gutierrez K. (2006) Herpes simplex virus infections. In: Ed. Remington J. Klein J. Wilson C. Baker C. (eds), Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA: Elsevier Saunders, pp. 845–865.
4. Balfour H. Jr (1999) Antiviral drugs. N Engl J Med 340: 1255–1268.
5. Bangen K. Delano-Wood L. Wierenga C. Stricker N. Hesselink J. Bondi M. (2010) Dementia following Herpes zoster encephalitis. Clin Neuropsychol 24: 1193–1203.
6. Baringer J. (2008) Herpes simplex infections of the nervous system. Neurol Clin 3:657–674.
7. Belec L. Tayot J. Tron P. Mikol J. Scaravilli F. Gray F. (1990) Cytomegalovirus encephalopathy in an infant with congenital acquired immuno-deficiency syndrome. Neuropaediatrics 21: 124–129.
8. Birx D. Redfield R. Tosato G. (1986) Defective regulation of Epstein–Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 314: 874–879.
9. Boivin G. (2004) Diagnosis of herpesvirus infections of the central nervous system. Herpes 11(Suppl. 2): 48A-56A.
10. Boivin G. Goyette N. Gilbert C. Humar A. Covington E. (2005) Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients. Transplant Infect Dis 7: 166–170.
11. Brambilla L. Romanelli A. Bellinvia M. Ferrucci S. Vinci M. Boneschi V. et al. (2008) Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases. Br J Dermatol 158: 1339–1344.
12. Braun D. Dominguez G. Pellett P. (1997) Human herpesvirus-6. Clin Microbiol Rev 10: 521–567.
13. Caserta M. Mock D. Dewhurst S. (2001) Human herpesvirus-6. Clin Infect Dis 33: 829–833.
14. Casrouge A. Zhang S. Eidenschenk C. Jouanguy E. Puel A. Yang K. et al. (2006) Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314: 308–312.
15. Celum C. Wald A. Lingappa J. Magaret A. Wang R. Mugo N. et al. (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 427–439.
16. Chan P. Ng H. Hui M. Cheng A. (2001) Prevalence and distribution of human herpesvirus 6 variants A and B in adult human brain. J Med Virol 64: 42–46.
17. Chang Y. Cesarman E. Pessin M. Lee F. Culpepper J. Knowles D. Moore P. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869.
18. Chien L. Whitley R. et al. (1975) (Boston Interhospital Virus Group and the NIAID Sponsored Cooperative Antiviral Clinical Study A) Failure of high dose 5-deoxyuridine in the therapy of herpes simplex virus encephalitis: evidence of unacceptable toxicity. N Engl J Med 292: 599–603.
19. Christophers J. Clayton J. Craske J. Ward R. Collins P. Trowbridge M. et al. (1998) Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 42: 868–872.
20. Cinque P. Bossolasco S. Vago L. Fornara C. Lipari S. Racca S. et al. (1997) Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? Clin Infect Dis 25: 634–639.
21. Cirone M. Cuomo L. Zompetta C. Ruggieri S. Frati L. Faggioni A. et al. (2002) Human herpesvirus 6 and multiple sclerosis: a study of T cell crossreactivity to viral and myelin basic protein antigens. J Med Virol 68: 268–272.
22. Clark D. Nacheva E. Leong H. Brazma D. Li Y. Tsao E. et al. (2006) Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 193: 912–916.
23. Davis L. Tyler K. (2005) Molecular diagnosis of CNS viral infections. J Neurol Neurosurg Psychiatry 76: 1–4.
24. de Biasi R. Kleinschmidt-De Masters B. Weinberg A. Tyler K. (2002) Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol 25: S5–S11.
25. de Clercq E. Naesens L. de Bolle L. Schols D. Zhang Y. Neyts J. (2001) Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev Med Virol 11: 381–395.
26. Delany S. Mlaba N. Clayton T. Akpomiemie G. Capovilla A. Legoff J. et al. (2009) Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo controlled trial in South Africa. AIDS 23: 461–469.
27. Denes E. Magy L. Pradeau K. Alain S. Weinbreck P. Ranger-Rogez S. (2004) Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg Infect Dis 10: 729–731.
28. Dennett C. Cleator G. Klapper P. (1997) HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom. J Med Virol 53: 1–3.
29. Di L. Kreuter A. Di T. Guarini A. Romano C. Montesarchio V. et al. (2008) Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study. J Invest Dermatol 128: 1578–1580.
30. Donati D. Akhyani N. Fogdell-Hahn A. Cermelli C. Cassiani-Ingoni R. Vortmeyer A. et al. (2003) Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61: 1405–1411.
31. Epstein M. Achong B. Barr Y. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1: 702–703.
32. Fujimoto H. Asaoka K. Imaizumi T. Ayabe M. Shoji H. Kaji M. (2002) Epstein-Barr virus infections of the central nervous system. Intern Med 42: 33–40.
33. Fukumoto H. Kanno T. Hasegawa H. Katano H. (2011) Pathology of Kaposi's sarcoma-associated herpesvirus infection. Front Microbiol 2: 175.
34. Gilden D. Cohrs R. Mahalingam R. Nagel M. (2009) Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 8: 731–740.
35. Gilden D. Kleinschmidt-De Masters B. LaGuardia J. Mahalingam R. Cohrs R. (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342: 635–645.
36. Gilden D. Mahalingam R. Cohrs R. Tyler K. (2007) Herpesvirus infections of the nervous system. Nat Clin Pract Neuro 3: 82–94.
37. Gnann J. Whitley R. (2002) Herpes zoster. N Engl J Med 347: 340–346.
38. Gnann J. Whitley R. (2004) Neurologic manifestations of varicella and herpes zoster. In: Ed. Scheld W. Whitley R. Marra C. (eds), Infections of the Central Nervous System (3rd edition). Philadelphia, PA: Lippincott Williams & Wilkins, pp. 146–157.
39. Gratama J. Ernberg I. (1995) Molecular epidemiology of Epstein–virus infection. Adv Cancer Res 67: 197–255.
40. Gregoire S. van Pesch V. Goffette S. Peeters A. Sindic C. (2006) Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry 77: 938–942.
41. Griffiths P. (2001) Herpesviruses: from the cradle to the grave. Microbiol Today 28: 182–184.
42. Griffiths P. McLaughlin J. (2004) Cytomegalovirus. In: Ed. Scheld W. Whitley R. Marra C. (eds), Infections of the central nervous system (3rd edition). Philadelphia, PA: Lippincott Williams & Wilkins, pp. 159–172.
43. Grover D. Newsholme W. Brink N. Manji H. Miller R. (2004) Herpes simplex virus infection of the central nervous system in human immunodeficiency virus-type 1-infected patients. Int J STD AIDS 15: 597–600.
44. Guo Y. Audry M. Ciancanelli M. Alsina L. Azevedo J. Herman M. et al. (2011) Herpes simplex virus encephalitis in a patient with complete TLR 3 deficiency: TLR 3 is otherwise redundant in protective immunity. J Exp Med 208: 2083–2098.
45. Haanpaa M. Dastidar P. Weinberg A. Levin M. Miettinen A. Lapinlampi A. et al. (1998) CSF and MRI findings in patients with acute herpes zoster. Neurology 51: 1405–1411.
46. Hacke W. (2010) Zosterinfektionen [Varicella-zoster-virus, VZV]. In: Ed. Hacke W. (ed.), Neurologie (13th edition). Heidelberg: Springer-Verlag, pp. 472–473.
47. Haeusler M. Schaade L. Kemeny S. Schweizer K. Schoenmackers C. Ramaekers V. (2002) Encephalitis related to primary varicella-zoster virus infection in immunocompetent children. J Neurol Sci 95: 111–116.
48. Heininger U. Seward J. (2006) Varicella. Lancet 368: 1365–1376.
49. Hengel H. (2012) Varicella-zoster-virus. In: Ed. Darai G. Handermann M. Sonntag H. Zöller L. (eds), Lexikon der Infektionskrankheiten des Menschen [Encyclopaedia of human infectious diseases]. (4th edition). Berlin: Springer-Verlag, pp. 915–917.
50. Hoover S. Ross J. Cohen J. (2004) Epstein-Barr virus. In: Ed. Scheld W. Whitley R. Marra C. (eds), Infections of the Central Nervous System (3rd edition). Philadelphia, PA: Lippincott Williams & Wilkins, pp. 175–183.
51. Humar A. Snydman D. (2009) AST infectious diseases community of practice cytomegalovirus in solid organ transplant recipients. Am J Transplant 9(Suppl. 4): S78–S86.
52. Isaacson E. Glaser C. Forghani B. Amad Z. Wallace M. Armstrong R. et al. (2005) Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 40: 890–893.
53. Ito H. Sayama S. Irie S. Kanazawa N. Saito T. Kowa H. et al. (1994) Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. Neurology 44: 1506–1507.
54. Jairam R. Baeten J. Wald A. Hughes J. Thomas K. Mujugira A. et al. (2010) Daily acyclovir delays HIV-1 disease progression among HIV-1/HSV-2 dually-infected persons: a randomized trial. Lancet 375: 824–833.
55. Jakob N. Handermann M. (2012) Herpes- simplex-virus. In: Ed. Darai G. Handermann M. Sonntag H. Zöller L. (eds), Lexikon der Infektionskrankheiten des Menschen [Encyclopaedia of human infectious diseases] (4th edition). Berlin: Springer-Verlag, pp. 389–392.
56. Jakob N. Handermann M. Darai G. (2008) Herpes- simplex-virus. In: Ed. Darai G. Handermann M. Sonntag H. Tidona C. Zöller L. (eds), Lexikon der Infektionskrankheiten des Menschen [Encyclopaedia of human infectious diseases] (3rd edition). Berlin: Springer-Verlag, pp. 388–391.
57. Jemsek J. Greenberg S. Taber L. Harvey D. Gershon A. Couch R. (1983) Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) 62: 81–97.
58. Kaul D. Stoelben S. Cober E. Ojo T. Sandusky E. Lischka P. et al. (2011) First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246. Am J Transplant 11: 1079–1084.
59. Kennedy P. Chaudhuri A. (2002) Herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 73: 237–238
60. Kessler H. Pierer K. Weber B. Sakrauski A. Santner B. Stuenzner D. et al. (1994) Detection of herpes simplex virus DNA from cerebrospinal fluid by PCR and a rapid, nonradioactive hybridization technique. J Clin Microbiol 32: 1881–1886.
61. Kimberlin D. (2003) Herpes simplex virus infections of the central nervous system. Semin Pediatr Infect Dis 14: 83–89.
62. Kimberlin D. (2007) Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes 14: 11–16.
63. Kimberlin D. Lin C. Sanchez P. Demmler G. Dankner W. Shelton M. et al. (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143: 16–25.
64. Kondo K. Kondo T. Shimada K. Amo K. Miyagawa H. Yamanishi K. (2002) Strong interaction between human herpesvirus 6 and peripheral blood monocytes / macrophages during acute infection. J Med Virol 67: 364–369.
65. Koskiniemi M. Piiparinen H. Rantalaiho T. Eränkö P. Färkkilä M. Räihä K. et al. (2002) Acute central nervous system complications in varicella zoster virus infections. J Clin Virol 25: 293–301.
66. Kubota T. Ito M. Maruyama K. Kato Y. Miyajima Y. Ogawa A. et al. (2006) Serial diffusion-weighted imaging of neonatal herpes encephalitis: a case report. Brain Dev 29: 171–173.
67. Kutok J. Wang F. (2006) Spectrum of Epstein–Barr virus-associated diseases. Annu Rev Pathol 1: 375–404.
68. Lassmann H. Niedobitek G. Aloisi F. Middeltorp J. (2011) Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held at the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 134: 2772–2786.
69. Leung T. Li C. Hung E. Chan P. Mo C. Wong R. et al. (2004) Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 72: 353–357.
70. Levin L. Munger K. O'Reilly E. Falk K. Ascherio A. (2010) Primary infection with Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 67: 824–830.
71. Li J. Sax P. (2009) HSV-1 encephalitis complicated by cerebral hemorrhage in an HIV-positive person. AIDS Read 19: 153–155.
72. Lischka P. Hewlett G. Wunberg T. Baumeister J. Paulsen D. Goldner T. et al. (2010) In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother 54: 1290–1297.
73. Lusso P. (2006) HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 37(Suppl. 1): S4–S10.
74. MacLean H. Douen A. (2002) Severe amnesia associated with human herpesvirus 6 encephalitis after bone marrow transplantation. Transplantation 73: 1086–1089.
75. Marin M. Guris D. Chaves S. Schmid S. Seward J. (2007) Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56: 1–40.
76. Martinez-Torres F. Menon S. Pritsch M. Victor N. Jenetzky E. Jensen K. et al. (2008) Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double blind, placebo controlled German, Austrian and Dutch trial. BMC Neurol 8: 40.
77. Meyding-Lamadé U. Oberlinner C. Rau P. Seyfer S. Heiland S. Sellner J. et al. (2003) Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities. J Neurovirol 9: 118–125.
78. Montagnino G. Bencini P.L. Tarantino A. Caputo R. Ponticelli C. (1994) Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol 14: 121–126.
79. Moore P. Gao S. Dominguez G. Cesarman E. Lungu O. Knowles D. et al. (1996) Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol 70: 549–558.
80. Moriuchi M. Moriuchi H. Williams R. Straus S. (2000) Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology 278: 534–540.
81. Mukai T. Yamamoto T. Kondo T. Kondo K. Okuno T. Kosuge H. et al. (1994) Molecular epidemiological studies of human herpesvirus 6 in families. J Med Virol 42: 224–227.
82. Musallam B. Matoth I. Wolf D. Engelhard D. Averbuch D. (2007) Steroids for deteriorating herpes simplex virus encephalitis. Pediatr Neurol 7: 229–232.
83. Nagot N. Ouedraogo A. Foulongne V. Konate I. Weiss H. Vergne L. et al. (2007) Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 356: 790–799.
84. Osman M. Kubo T. Gill J. Neipel F. Becker M. Smith G. et al. (1999) Identification of human herpesvirus 8-specific cytotoxic T-cell responses. J Virol 73: 6136–6140.
85. Pass R. Zhang C. Evans E. Simpson T. Andrews W. Huang M. et al. (2009) Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 360: 1191–1199.
86. Pedneault L. Katz B. Miller G. (1992) Detection of Epstein-Barr virus in the brain by the polymerase chain reaction. Ann Neurol 32: 184–192.
87. Pelligra G. Lynch N. Miller S. Sargent M. Osiovich H. (2007) Brainstem involvement in neonatal herpes simplex virus type 2 encephalitis. Pediatrics 120: e442–e446.
88. Pérez de Diego R. Sancho-Shimizu V. Lorenzo L. Puel A. Plancoulaine S. Picard C. et al. (2010) Human TRAF 3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:400–411.
89. Persson A. Bergström T. Lindh M. Namvar L. Studahl M. (2009) Varicella-zoster virus CNS disease – viral load, clinical manifestations and sequels. J Clin Virol 46: 249–253.
90. Pinot de Moira A. Nardone A. for the ESEN 2 Group (2005) Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill 10: 43–45.
91. Posavad C. Wald A. Kuntz S. Huang M. Selke S. Krantz E. et al. (2004) Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. J Infect Dis 190: 693–696.
92. Price R. Horta-Barbosa L. Posner J. (1973) Herpes simplex encephalitis in an anergic patient. Am J Med 54: 222–228.
93. Rapaport D. Engelhard D. Tagger G. Or R. Frenkel N. (2002) Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transplant Infect Dis 4: 10–16.
94. Rebbapragada A. Wachihi C. Pettengell C. Sunderji S. Huibner S. Jaoko W. et al. (2007) Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2: 589–598.
95. Reuter J. Gomez D. Wilson J. van den Pol A. (2004) Systemic immune deficiency necessary for cytomegalovirus invasion of the mature brain. J Virol 78: 1473–1487.
96. Roos K. Tyler K. (2010) Meningitis, encephalitis, brain abscess and empyema. In: Ed. Hauser S. Josephson S. (eds), Harrison's Neurology in Clinical Medicine (2nd edition). New York: McGraw Hill, pp. 465–471.
97. Rösen-Wolff A. (2012) Epstein-Barr-virus. In: Ed. Darai G. Handermann M. Sonntag H. Zöller L. (eds), Lexikon der Infektionskrankheiten des Menschen [Encyclopaedia of human infectious diseases] (4th edition). Berlin: Springer-Verlag, pp. 289–291.
98. Salahuddin S. Ablashi D. Markham P. Josephs S. Sturzenegger S. Kaplan M. et al. (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234: 596–601.
99. Sawada J. Nakatani-Enomoto S. Aizawa H. Katayama T. Ito T. Aburakawa Y. et al. (2007) An adult case of relapsing human herpesvirus-6 encephalitis. Intern Med 46: 1617–1620.
100. Schacker T. Zeh J. Hu H. Shaughnessy M. Corey L. (2002) Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 186: 1718–1725.
101. Schiff D. Rosenblum M. (1998) Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol 29:215–222.
102. Schmutzhard E. (2001) Viral infections of the CNS with special emphasis on herpes simplex infections. J Neurol 248: 469–477.
103. Seeley W. Marty F. Holmes T. Upchurch K. Soiffer R. Antin J. et al. (2007) Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 69: 156–165.
104. Smith A. Paolucci C. Lullo G. Burastero S. Santoro F. Lusso P. (2005) Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J Virol 79: 2807– 2813
105. Stagno S. (2000) Cytomegalovirus. In: Ed. Remington J. Klein J. (eds), Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B. Saunders, pp. 389–424.
106. Steiner I. (2011) Herpes simplex virus encephalitis: new infection or reactivation? Curr Opin Neurol 24: 268–274.
107. Stratton K. Durch J. Lawrence R. (eds) (2001) Vaccines for the 21st Century: A Tool for Decision Making. Washington, DC: National Academy Press.
108. Suligoi B. Dorrucci M. Volpi A. Andreoni M. Rezza G. (2002) No protective effect of acyclovir on HIV disease progression in a cohort of HSV-2–HIV-infected individuals. Antivir Ther 7: 289–291.
109. Sullivan B. Coscoy L. (2008) Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 U 24 protein. J Virol 82: 602–608.
110. Takahashi K. Sonoda S. Higashi K. Kondo T. Takahashi H. Takahashi M. et al. (1989) Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J Virol 63: 3161–3163.
111. Tanaka-Taya K. Sashihara J. Kurahashi H. Amo K. Miyagawa H. Kondo K. et al. (2004) Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 73: 465–473.
112. Tang J. Coward L. Davies N. Geretti A. Howard R. Hirsch N. et al. (2003) Brainstem encephalitis caused by primary herpes simplex 2 infection in a young woman. J Neurol Neurosurg Psychiatry 74: 1323–1325.
113. Taylor-Wiedeman J. Sissons J. Borysiewicz L. Sinclair J. (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72: 2059–2064.
114. Toth C. Harder S. Yager J. (2003) Neonatal herpes encephalitis: a case series and review of clinical presentation. Can J Neurol Sci 30: 36–40.
115. Troy S. Blackburn B. Yeom K. Caulfield A. Bhangoo M. Montoya J. (2008) Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. Clin Infect Dis 47: e93–e96.
116. Tselis A. Duman R. Storch G. Lisak R. (1997) Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology 48: 1351–1355.
117. Upton A. Grumpert J. (1970) Electroencephalography in diagnosis of herpes simplex encephalitis. Lancet 1: 650–652.
118. van der Bij W. Speich R. (2001) Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis 33(Suppl. 1): S32–S37.
119. Vinters H. Kwok M. Ho H. Anders K. Tomiyasu U. Wolfson W. et al. (1989) Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 112: 245–268.
120. Vossough A. Zimmerman R. Bilaniuk L. Schwartz E. (2008) Imaging findings of neonatal herpes simplex virus type 2 encephalitis. Neuroradiology 50: 355–366.
121. Wainwright M. Martin P. Morse R. Lacaze M. Provenzale J. Coleman R. et al. (2001) Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 50: 612–619.
122. Ward K. Leong H. Thiruchelvam A. Atkinson C. Clark D. (2007) Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis. J Clin Microbiol 45: 1298–1304.
123. Weinberg A. Li S. Palmer M. Tyler K. (2002) Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol 52: 543–548.
124. Weiss H. (2004) Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11(Suppl. 1): 24A–35A.
125. Weiss L. Movahed L. Warnke R. Sklar J. (1989) Detection of Epstein–Barr viral genomes in Reed–Sternberg cells of Hodgkin's disease. N Engl J Med 320: 502–506.
126. Whitley R. (1990) Viral encephalitis. N Engl J Med 323: 242–250.
127. Whitley R. (2004) Herpes simplex virus. In: Ed. Scheld W. Whitley R. Marra C. (eds), Infections of the Central Nervous System (3rd edition). Philadelphia, PA: Lippincott Williams & Wilkins, pp. 123–144.
128. Whitley R. Gnann J. (2002) Viral encephalitis: familiar infections and emerging pathogens. Lancet 359: 507–513.
129. Whitley R. Nahmias A. Visintine A. Fleming C. Alford C. (1980) The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 66: 489–494.
130. Whitley R. Soong S. Hirsch M. Karchmer A. Dolin R. Galasso G. et al. (1981) Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med 304: 313–318.
131. Williams H. McAulay K. Macsween K. Gallacher N. Higgins C. Harrison N. et al. (2005) The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 129: 266–274.
132. Williamson W. Demmler G. Percy A. Catlin F. (1992) Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 90: 862–866.
133. Winceslaus J. (1998) Regression of AIDS-related pleural effusion with HAART: highly active antiretroviral therapy. Int J STD AIDS 9: 368–370.
134. World Health Organization (1998) The WHO position paper on varicella vaccines. Wkly Epidemiol Rec 73: 241–248.
135. Yamanishi K. Okuno T. Shiraki K. Takahashi M. Kondo T. Asano Y. et al. (1988) Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1: 1065–1067.
136. Zhu H. Zheng C. Xing J. Wang S. Li S. Lin R. et al. (2011) Varicella-zoster virus immediate-early protein ORF 61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. J Virol.85: 11079–11089.
137. Zur Hausen H. Schulte-Holthausen H. Klein G. Henle W. Henle G. Clifford P. et al. (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056–1058.